StockData
Lifecore Biomedical, Inc. logo

Lifecore Biomedical, Inc. (LFCR) stock

LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
Financials through Q4 FY2025, quarter ended May 25, 2025Last filing: 10-Q on Nov 4, 2026Score 4/30
$6.39−0.03 (-0.39%)

Close on Nov 17, 2026Market cap $241.88MP/E –Yield –

Lifecore Biomedical operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Lifecore Biomedical's operating income for the twelve months ending May 25, 2025 was -$17.25M. For fiscal 2025 it was -$17.25M. The highest annual figure on record is $24.87M in fiscal 2013.

Annual operating income

PeriodPeriod endValueChange
FY2025May 25, 2025-$17.25M–
FY2024May 26, 2024-$8.84M–
FY2023May 28, 2023-$21.80M–
FY2022May 29, 2022-$11.79M–
FY2021May 30, 2021-$8.82M–
FY2020May 31, 2020-$25.88M-572.6%
FY2019May 26, 2019$5.48M-59.7%
FY2018May 27, 2018$13.59M-7.4%
FY2017May 28, 2017$14.67M–
FY2016May 29, 2016-$20.63M-211.7%
FY2015May 31, 2015$18.46M-8.6%
FY2014May 25, 2014$20.19M-18.8%
FY2013May 26, 2013$24.87M+70.6%
FY2012May 27, 2012$14.58M+81.5%
FY2011May 29, 2011$8.03M+0.6%
FY2010May 30, 2010$7.98M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ2 2025May 25, 2025$5.33M+147.9%
Q3 FY2025CQ1 2025Feb 23, 2025-$9.03M–
Q2 FY2025CQ4 2024Nov 24, 2024-$1.96M–
Q1 FY2025CQ3 2024Aug 25, 2024-$11.58M–
Q4 FY2024CQ2 2024May 26, 2024$2.15M–
Q3 FY2024CQ1 2024Feb 25, 2024-$895.00K–
Q2 FY2024CQ4 2023Nov 26, 2023-$1.48M–
Q1 FY2024CQ3 2023Aug 27, 2023-$8.61M–
Q4 FY2023CQ2 2023May 28, 2023-$6.64M–
Q3 FY2023CQ1 2023Feb 26, 2023-$6.53M–
Q2 FY2023CQ4 2022Nov 27, 2022-$5.35M-245.0%
Q1 FY2023CQ3 2022Aug 28, 2022-$3.27M–
Q4 FY2022CQ2 2022May 29, 2022-$2.51M–
Q3 FY2022CQ1 2022Feb 27, 2022-$9.64M-13302.7%
Q2 FY2022CQ4 2021Nov 28, 2021$3.69M+168.6%
Q1 FY2022CQ3 2021Aug 29, 2021-$4.22M–
Q4 FY2021CQ2 2021May 30, 2021-$6.63M–
Q3 FY2021CQ1 2021Feb 28, 2021$73.00K–
Q2 FY2021CQ4 2020Nov 29, 2020$1.37M–
Q1 FY2021CQ3 2020Aug 30, 2020-$10.60M–
Q4 FY2020CQ2 2020May 31, 2020-$449.00K-118.1%
Q3 FY2020CQ1 2020Feb 23, 2020-$15.01M-563.0%
Q2 FY2020CQ4 2019Nov 24, 2019-$6.04M-60460.0%
Q1 FY2020CQ3 2019Aug 25, 2019-$4.38M–
Q4 FY2019CQ2 2019May 26, 2019$2.48M-69.3%
Q3 FY2019CQ1 2019Feb 24, 2019$3.24M-7.0%
Q2 FY2019CQ4 2018Nov 25, 2018$10.00K–
Q1 FY2019CQ3 2018Aug 26, 2018-$257.00K-109.4%
Q4 FY2018CQ2 2018May 27, 2018$8.07M+402.9%
Q3 FY2018CQ1 2018Feb 25, 2018$3.49M-19.5%
Q2 FY2018CQ4 2017Nov 26, 2017-$695.00K-121.3%
Q1 FY2018CQ3 2017Aug 27, 2017$2.73M-50.2%
Q4 FY2017CQ2 2017May 28, 2017$1.61M-74.3%
Q3 FY2017CQ1 2017Feb 26, 2017$4.33M–
Q2 FY2017CQ4 2016Nov 27, 2016$3.26M–
Q1 FY2017CQ3 2016Aug 28, 2016$5.47M–
Q4 FY2016CQ2 2016May 29, 2016$6.25M–
Q3 FY2016CQ1 2016Feb 28, 2016-$33.62M–

More Lifecore Biomedical figures

See a number that looks wrong?